Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Genelux Corp has a consensus price target of $23 based on the ratings of 6 analysts. The high is $40 issued by Maxim Group on September 12, 2023. The low is $8 issued by Guggenheim on October 29, 2024. The 3 most-recent analyst ratings were released by HC Wainwright & Co., Guggenheim, and Roth MKM on November 15, 2024, October 29, 2024, and August 27, 2024, respectively. With an average price target of $16 between HC Wainwright & Co., Guggenheim, and Roth MKM, there's an implied 527.45% upside for Genelux Corp from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for Genelux (NASDAQ:GNLX) was reported by HC Wainwright & Co. on November 15, 2024. The analyst firm set a price target for $30.00 expecting GNLX to rise to within 12 months (a possible 1076.47% upside). 11 analyst firms have reported ratings in the last year.
The latest analyst rating for Genelux (NASDAQ:GNLX) was provided by HC Wainwright & Co., and Genelux maintained their buy rating.
There is no last upgrade for Genelux
There is no last downgrade for Genelux.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Genelux, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Genelux was filed on November 15, 2024 so you should expect the next rating to be made available sometime around November 15, 2025.
While ratings are subjective and will change, the latest Genelux (GNLX) rating was a maintained with a price target of $32.00 to $30.00. The current price Genelux (GNLX) is trading at is $2.55, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.